Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GUCY1B3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SSTR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRMD4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WDTC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDOB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6727 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UTP15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC285847 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SNTB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNAR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANOS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNASEH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXNDC17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on